GS UHL (Votrient pazopanib 400 mg)

Generic Name: pazopanib

Pill imprint GS UHL has been identified as Votrient pazopanib 400 mg.

Votrient is used in the treatment of renal cell carcinoma; soft tissue sarcoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Votrient

Generic Name:

pazopanib

Imprint:

GS UHL

Strength:

pazopanib 400 mg

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

VEGF/VEGFR inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

GlaxoSmithKline

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.